The Department of Veterans Affairs today announced its proposed access standards for the new Veterans Community Care Program to begin in June under the AHA-supported MISSION Act of 2018. VA said the access standards, to be published in the Federal Register, will be based on average drive time and appointment wait times. Eligible veterans who cannot access care within those standards would be able to choose between eligible community providers and care at a VA medical facility.

Specifically, the agency proposes:

  • a 30-minute average drive time standard for primary care, mental health and non-institutional extended care services;
  • a 60-minute average drive time standard for specialty care; and 
  • appointment wait-time standards of 20 days for primary care, mental health care and non-institutional extended care services; and 28 days for specialty care from the date of request with certain exceptions.

“Strict and confusing qualification criteria like driving distances and proximity to VA facilities that don’t offer needed services will be replaced by eligibility guidelines based on what matters most: the convenience of our veteran customers,” said VA Secretary Robert Wilkie. 

Related News Articles

Headline
An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug Pricing Program.  “When…
Headline
The American Medical Association Dec. 16 released its latest annual report on health insurance competition, finding that 97% of commercial markets were highly…
Headline
Approximately 950,000 consumers who currently do not have health insurance coverage through the federally facilitated Health Insurance Marketplace have signed…
Headline
The Senate today failed to pass legislation to address health care affordability. The chamber first voted on a Republican-backed bill that failed by a 51-…
Headline
The AHA Dec. 9 expressed support for the Critical Access for Veterans Care Act (S. 1868), legislation that would expand veteran access to critical access…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…